Uncategorized

Physician Dispensing Overview I

Physician dispensing continues to grow as a mechanism for practices to supplement their revenue and extend their service to patients.  Simply put, physician dispensing is the act of providing medications to patients in lieu of going to a pharmacy.  In most states, prescribers are authorized to dispense pharmaceuticals to their own patients.  Normally, the practitioner provides prepackaged medications in unit-of-use sizes.  This means that the drugs are packaged in the dispensed size so the physician or nurse practitioner doesn’t have to count pills.

There are many companies playing in the physician dispensing market.  Most of them are brokers that resell products sitting on a distributors shelves.  There are a handful of companies that maintain state and federal licensure to distribute pharmaceuticals.  Typically, clinics purchase generic products for their clinic dispensing programs.  Some clinics purchase programs to accept insurance but this typically creates another level of complexity with minimal profit to the practice.

Schedule a free claims analysis now.

Let’s Talk now

Leader in AI-driven health benefits navigation Healthee partners with Northwind

Katherine Lurk | Mar 28th, 2025
A game-changer for employers looking to cut costs and gain control With healthcare costs continuing to rise, employers are seeking new ways to rein in spending without sacrificing the quality of benefits. This partnership enables Healthee clients to optimize prescription drug management, reducing costs through preferable generic drug pricing, high-touch chronic care programs, and more. … more »

continue reading

Healthcare Storm 2025: What Will It Be?

Phillip Berry | Jan 1st, 2025
When it comes to American healthcare, we’ve become really good at highlighting its failings. Watching the flurry of lamentations, frustrations, denigrations, and prognostications, over the last few weeks, would lead any rational person to believe that nothing is working in our healthcare system. And, not only is it “not working,” many people conclude that it … more »

continue reading

New Drugs to Market – October Update

Phillip Berry | Oct 25th, 2024
The Food and Drug Administration (FDA) approved three novel drug therapies in October. One of those therapies,  Hympavzi (marstacimab-hncq), is a medication indicated for the treatment of patients with Hemophilia A and Hemophilia B. Hympavzi utilizes a new pathway to help reduce the risk of bleeding episodes in patients with Hemophilia, a disease that impacts … more »

continue reading